P

Inventor

DUBUISSON JEAN-FRANÇOIS

FR32 patents
⚠️ This page may combine multiple inventors who share the name “DUBUISSON JEAN-FRANÇOIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FLAMEL IRELAND LTD

31 patents
US10272062B2Apr 30, 2019

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD68 citations99
US11896572B2Feb 13, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD28 citations98
US11826335B2Nov 28, 2023

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD27 citations98
US11766418B2Sep 26, 2023

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD27 citations98
US11602513B1Mar 14, 2023

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD36 citations98
US10736866B2Aug 11, 2020

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD53 citations98
US12138239B2Nov 12, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD9 citations94
US12128021B1Oct 29, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD12 citations94
US12115143B2Oct 15, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD10 citations94
US12115142B2Oct 15, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD10 citations94
US12115144B2Oct 15, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD10 citations94
US12115145B2Oct 15, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD10 citations94
US12097175B2Sep 24, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD9 citations94
US11986451B1May 21, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD24 citations94
US11602512B1Mar 14, 2023

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD36 citations94
US11583510B1Feb 21, 2023

Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

FLAMEL IRELAND LTD37 citations94
US11504347B1Nov 22, 2022

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD38 citations94
US11779557B1Oct 10, 2023

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD7 citations85
US12263150B2Apr 1, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations75
US12263151B2Apr 1, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations75
US12257223B2Mar 25, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD2 citations75
US12239625B2Mar 4, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations75
US12226388B2Feb 18, 2025

Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD2 citations75
US12226389B2Feb 18, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations75
US12186298B2Jan 7, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations75
US12144793B2Nov 19, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD0 citations73
US12109186B2Oct 8, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD1 citations73
US12551457B1Feb 17, 2026

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD0 citations62
US12478604B1Nov 25, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD0 citations62
US12295926B1May 13, 2025

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD0 citations62
US12097176B2Sep 24, 2024

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

FLAMEL IRELAND LTD0 citations62

MAAT PHARMA

1 patent